Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01602939
Recruitment Status : Recruiting
First Posted : May 21, 2012
Last Update Posted : August 29, 2016
Information provided by (Responsible Party):
LUIS ESCRIBANO, Hospital Virgen de la Salud

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2017
  Estimated Study Completion Date : June 2017